低代阴离子害虫:解决耐药性药物的新方法
Evgeny Apartsin1,2,3, Abdul Akhir4, Grace Kaul4,5
1Laboratoire de Chimie de Coordination du CNRS, 205 Route de Narbonne, BP 44099, 31077 Toulouse Cedex 4, France.
Biomacromolecules
|June 3, 2023
概括
一种新型的酸盐-树体,AE4G0,显示出强大的抗微生物活性,对抗药物耐药的细菌,如甲素耐药的金黄色葡萄球菌 (MRSA). 它有效治疗感染,并与现有的抗生素协同作用,提供了一个有前途的新疗法选择.
科学领域:
- 微生物学 微生物学
- 药用化学 医学化学
- 传染性疾病 传染性疾病
背景情况:
- 抗菌素耐药性 (AMR) 构成了全球健康的重大威胁,导致病率,死亡率和经济损失的增加.
- 耐甲基西林黄金葡萄球菌 (MRSA) 感染的死亡率较高,治疗选择有限.
- 迫切需要新型抗菌剂来对抗耐药性细菌感染.
研究的目的:
- 为了合成和评估一种新型的酸树脂聚合物,AE4G0,其抗菌活性.
- 评估AE4G0对黄金葡萄球菌和菌菌种,包括耐药菌株的疗效.
- 调查AE4G0作为对抗药性黄金色杆菌感染的治疗选择的潜力.
主要方法:
- 合成AE4G0,一种低代阴离子树突.
- 在体外对S. aureus和Enterococcus sp.进行抗微生物敏感性测试.
- 显微镜 (光和扫描电子) 可视化细菌的破坏.
- 在小鼠皮肤感染模型中进行体内疗效测试.
- 与 gentamicin 对抗耐药MRSA菌株的协同效应测试.
主要成果:
- AE4G0表现出强烈的,与度相关的杀菌活性,可对抗S. aureus和Enterococcus sp.
- AE4G0对真核细胞具有广泛的选择性.
- 显微镜证实AE4G0诱导了S. aureus的彻底毁灭,在重复暴露后没有产生耐药性.
- AE4G0在体内表现出显著的疗效,无论是单独的还是与 gentamicin 对抗耐药MRSA的组合.
- 在AE4G0和 gentamicin之间观察到协同活性,以对抗抗 gentamicin 耐药的MRSA.
结论:
- AE4G0是一种有前途的新型抗菌剂,对抗药物耐药性黄金色细菌具有强烈活性.
- 树突分子AE4G0在临床前模型中显示出有效性,并有潜力治疗局部耐药黄金色杆菌感染.
- AE4G0代表了一种潜在的新疗法策略,以应对抗菌素耐药性的挑战.
相关概念视频
01:17Pore Transport and Ion-Pair Transport
528
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
528
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:26Targets for Drug Action: Overview
6.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.5K